Hallie Kendis
Internal Medicine · Willoughby Hills, OHNPI 1285967919
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,039 and has fallen 98.3% since, to $18 in 2025.
Across 159 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$537
- Novartis$348
- Inspire Medical Systems, Inc.$304
- Sanofi$232
- UCB, Inc.$206
- Biogen$121
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,96199%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $537 |
| Novartis | 22 | $348 |
| Inspire Medical Systems, Inc. | 3 | $304 |
| Sanofi | 13 | $232 |
| UCB, Inc. | 8 | $206 |
| Biogen | 8 | $121 |
| Lundbeck LLC | 6 | $99 |
| Greenwich Biosciences, Inc. | 5 | $91 |
| Teva Pharmaceuticals USA, Inc. | 6 | $89 |
| CSL Behring | 5 | $84 |
| Lilly USA, LLC | 6 | $84 |
| Harmony Biosciences LLC | 2 | $81 |
| Genentech USA, Inc. | 6 | $73 |
| SK Life Science, Inc. | 4 | $62 |
| AstraZeneca | 3 | $61 |
| Jazz Pharmaceuticals Inc. | 3 | $45 |
| Neurocrine Biosciences, Inc. | 3 | $43 |
| Amgen | 2 | $37 |
| Acadia Pharmaceuticals Inc | 2 | $34 |
| Eisai Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| Merz North America, Inc. | 2 | $28 |
| Portola Pharmaceuticals, LLC | 2 | $26 |
| Boston Scientific | 1 | $21 |
| Merck | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $18 |
| Assertio Therapeutics, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Bausch Health US, LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Promius Pharma LLC | 1 | $16 |
| Acorda Therapeutics, Inc | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| EMD Serono, Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Tanabe Pharma America, Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
| Kyowa Kirin, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,989 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Willoughby Hills
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
- Richard KimDayton$326K
- Marina MagreyCleveland$312K
- Lisa LarkinCincinnati$276K
- Gregg FaimanMayfield Hts$274K
- Vincent MartinCincinnati$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.